Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI

Objective To evaluate active inflammatory lesions (AIL) and structural changes (SC) in patients with active non-radiographic axial spondyloarthritis (nr-axSpA) compared with patients with ankylosing spondylitis (AS) on whole-body MRI (wb-MRI). Method 75 patients with active disease and a symptom duration of <5 years (39 with AS and 36 with nr-axSpA) were investigated with a comprehensive wb-MRI protocol and scored for AIL and SC in the spine, sacroiliac joints (SIJs) and non-axial manifestations. Results 92% of patients with AS showed active inflammation in the SIJ, 53% in the spine and 94% and 39%, respectively, in the nr-axSpA group. There was a non-significant trend towards more inflammation in patients with AS compared with patients with nr-axSpA in SIJs and spine. Peripheral enthesitis/osteitis was more common in patients with AS (n=22) than in those with nr-axSpA (n=12) (p=0.05). SC were more common in patients with AS than in those with nr-axSpA, with significantly higher scores for SIJ fatty bone marrow deposition (FMD) in patients with AS (4.8±3.2) compared with those with nr-axSpA (2.4±2.7; p=0.001) and more frequent bone proliferation in the spine and the SIJ (p=0.02 and p=0.005, respectively). SIJ erosions were more common in AS (score 4.2±2.3) than in nr-axSpA (score 3.8±1.8) patients (not significant). Conclusions Wb-MRI detects active inflammation and SC more frequently in the SIJs than in the spine. Half of the patients showed inflammation in non-axial sites. Active inflammatory and structural lesions were present both in patients with AS and those with nr-axSpA, being only slightly more common in patients with AS.

[1]  A. Djamali,et al.  Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.

[2]  B. Hamm,et al.  Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis , 2007, Annals of the rheumatic diseases.

[3]  J. Hodler,et al.  The diagnostic utility of MRI in spondyloarthritis: An international multicentre evaluation of 187 subjects (The MORPHO study) , 2010 .

[4]  M. Dougados,et al.  Assessment of enthesitis in ankylosing spondylitis , 2003, Annals of the rheumatic diseases.

[5]  P. Emery,et al.  Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis. , 2009, Arthritis and rheumatism.

[6]  J. Braun,et al.  Magnetresonanztomographie der Sakroiliitis: Anatomie, Pathohistologie, MR-Morphologie und Graduierung , 2004, Der Radiologe.

[7]  W. Maksymowych,et al.  Systematic assessment of inflammation by magnetic resonance imaging in the posterior elements of the spine in ankylosing spondylitis , 2010, Arthritis care & research.

[8]  D. M. van der Heijde,et al.  Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. , 2003, Arthritis and rheumatism.

[9]  B. Hamm,et al.  Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. , 2003, Arthritis and rheumatism.

[10]  D. M. van der Heijde,et al.  Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group , 2009, Annals of the rheumatic diseases.

[11]  J. Hodler,et al.  The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. , 2010, Arthritis and rheumatism.

[12]  D. M. van der Heijde,et al.  Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems , 2004, Annals of the rheumatic diseases.

[13]  E. Märker-Hermann,et al.  The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. , 2009, Arthritis and rheumatism.

[14]  M. Cohen,et al.  Peripheral arthritis in ankylosing spondylitis. A review of 209 patients followed up for more than 20 years. , 1983, Mayo Clinic proceedings.

[15]  J. Sieper,et al.  Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab. , 2007, The Journal of rheumatology.

[16]  J. Listing,et al.  Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48 , 2011, Annals of the rheumatic diseases.

[17]  B. Hamm,et al.  Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium? , 2009, European journal of radiology.

[18]  K. Wolf,et al.  Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging. , 1995, Radiology.

[19]  Ulrich Weber,et al.  Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis , 2007, BMC musculoskeletal disorders.

[20]  N. V. Bunchuk,et al.  Spinal inflammation lesions as detected by magnetic resonance imaging in patients with early ankylosing spondylitis are more often observed in posterior structures of the spine. , 2010, Rheumatology.

[21]  D. M. van der Heijde,et al.  Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging , 2004, Annals of the rheumatic diseases.

[22]  A. Calin,et al.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.

[23]  M. Taupitz,et al.  Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides. , 2002, Clinical and experimental rheumatology.

[24]  D. M. van der Heijde,et al.  Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities , 2005, Arthritis research & therapy.

[25]  L. Coates,et al.  Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. , 2009, Arthritis and rheumatism.

[26]  D. M. van der Heijde,et al.  Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary? , 2005, The Journal of rheumatology.

[27]  B. Hamm,et al.  Role of whole-body magnetic resonance imaging in diagnosing early spondyloarthritis. , 2009, European journal of radiology.

[28]  K. Rufibach,et al.  Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. , 2009, Arthritis and rheumatism.

[29]  J. Braun,et al.  MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis , 2007, Annals of the rheumatic diseases.

[30]  Chang-Youh Tsai,et al.  Undifferentiated spondyloarthropathy in Chinese patients. , 2006, Archives of medical research.

[31]  M. Dougados,et al.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection , 2009, Annals of the rheumatic diseases.

[32]  P. Emery,et al.  The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy , 2009, Annals of the rheumatic diseases.

[33]  B. Dijkmans,et al.  Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). , 2005, Arthritis and rheumatism.

[34]  M. Reiser,et al.  Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making. , 2011, European journal of radiology.

[35]  T. Fischer,et al.  [Magnetic resonance tomography of sacroiliitis: anatomy, histological pathology, MR-morphology, and grading]. , 2004, Der Radiologe.

[36]  John C. Davis,et al.  MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. , 2006, AJR. American journal of roentgenology.

[37]  L. Carmona,et al.  Early spondyloarthritis: results from the pilot registry ESPIDEP. , 2010, Clinical and experimental rheumatology.

[38]  Jürgen Braun,et al.  Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial. , 2006, Arthritis and rheumatism.

[39]  R. Landewé,et al.  Description of spinal MRI lesions and definition of a positive MRI of the spine in axial SpA , 2010 .

[40]  Andreas Krause,et al.  Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial , 2011, Annals of the rheumatic diseases.

[41]  P. Emery,et al.  Early inflammatory clinics. Experience with early arthritis/back pain clinics. , 2009, Clinical and experimental rheumatology.